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The coexistence of ulcerative colitis and focal segmen-
tal glomerulosclerosis is a rare condition. Mesalamine and/or
sulfasalazine which have been used in ulcerative colitis treat-
ment may be nephrotoxic. In our case, we have detected
togetherness between ulcerative colitis and non-drug-induced
focal segmental glomerulosclerosis. It should be kept in mind
that the two diseases may be caused by an unknown factor
such as genetic, environmental or infections except drugs.
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Acute  renal  failure  secondary
and Fanconi  syndrome  due to
Fracaso  renal  agudo  por  nefritis  in
Fanconi  en  relación  con  metamizo
To the Editor:
We  present a case of acute interstitial nephropathy (AIN) asso
ciated with Fanconi syndrome, resolving after early treatmen
with steroids.
A 49-year-old man  with a past medical history of alco
holic pancreatitis and liver disease, hypertriglyceridemia, an
hypertension (HTN) treated with gemﬁbrozil and valsartan fo
over one year.
Two months ago, he had undergone an umbilical herni
repair. At that time, plasma creatinine was 0.79 mg/dl and uri-
nalysis was normal. He received a cephalosporin, and 3 weeks
of analgesia in the form of metamizole and paracetamol, with
complete recovery. Two weeks later, metamizole was restarted
at a dose of 575 mg/8 h orally for ﬂu-like symptoms. He devel-
oped progressive weakness, abdominal pain, and nausea.
Oral intake was reduced and BP control worsened, therefore
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 interstitial  acute  nephritis
etamizole  and  gemﬁbrozil
rsticial  aguda  con  síndrome  de
 gemﬁbrozilo
the doses of valsartan and metamizole were increased, with
additional paracetamol as required. His general condition
worsened, therefore he attended the emergency departmen
where BP was 135/85. Skin and mucous membranes were dry
he was afebrile, with no skin lesions, and no other physica
ﬁndings. He had a high urine output (3.5 L/day), which wa
macroscopically normal. Blood tests showed a full blood coun
with no eosinophilia, metabolic acidosis with normal lactic
acid, normal CK, reduced glomerular ﬁltration rate (GFR)
hypouricemia, and a mixed proteinuria of 1.4 g/24 h. Urinaly Gutiérrez-Sánchez MJ, Pedraza-Cezón L. Fracaso renal agudo por
etamizol y gemﬁbrozilo. Nefrologia. 2016;36:321–323.
microhaematuria, isosthenuria, and the presence of granular
hyaline casts.4,5 There was reduced tubular reabsorption of
phosphate, potassium, calcium, and uric acid, and gener-
alised hyperaminoaciduria. Abdominal ultrasound showed
kidneys measuring 146 mm with preserved corticomedullary
differentiation and no signs of hydronephrosis. There were
no abnormalities of the bladder or prostate. Viral serology and
tumour markers were negative. Immunology was normal,
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Table 1 – Investigation results.
Values Initial Nadir 12 weeks
Urea (mg/dl) 88 40
FE urea (%) 24  64 35
Creatinine (mg/dl) 4.4 1.14
ClCr (ml/min) 19 15 Estimated GFR using MDRD-IDMS >60
BUN/Cr 9 7 16
pH plasma 7.25 7.35
Bicarbonate (mEq/l) 15 23
Albumin (g/dl) 2.6 2.4 4.3
Anion gap (mMol/l) 17 15 16
UAG (mEq/l) +5 +17 –
Calcium (mg/dl) 8.9 8.0 8.7
Phosphorus (mg/dl) 4.2 5.6 2.7
Uric acid (mg/dl) 3.6 2.1 6.0
Potassium (mMol/l) 5.8 3.8 4.7
Ca/GFR (mg/dl) 0.24
TRF (%) 80 54 90
FE AU (%) 33 9
FE K+ (%) 23 44 9
FE Na+ (%) 2.6 4.8 0.5
Urine pH 6.0 7.0 6.0
Proteinuria 99 mg/dl 1.4 g/24 h Dipstick Neg.
Glycosuria 100 mg/dl Dipstick Neg.
Aminoaciduria Positive, generalised Normal
including complement, ANA, ANCA, anti-GBM, and protein
electrophoresis and immunoglobulins. Intact parathyroid
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al  Mantoux negative; and CXR, normal (investigation
sults, Table 1). Pre-renal factors were corrected, but with no
provement in GFR, therefore renal biopsy was performed.
his showed 13 glomeruli with no abnormalities, interstitial
edema, an intense lymphoid inﬁltrate accompanied with
olymorphonuclear neutrophils and eosinophils, no granu-
ma, acute tubular necrosis, normal arteries and arterioles,
d no complement or immune-complex deposits on direct
munoﬂuorescence. A diagnosis was made of acute renal
ilure due to tubular necrosis and acute interstitial nephritis
IN) secondary to metamizole, and Fanconi syndrome.
eatment was started with methylprednisolone 250 mg/day
r 3 days and was then switched to prednisone 1 mg/kg/day
 a reducing dose until it was stopped 12 weeks later, once
e GFR had recovered and the tubular abnormalities had
solved.
Acute interstitial nephritis comprises 15–27% of ﬁndings in
nal biopsy.1 Recent years have seen a change in the clin-
al pattern and causative agents.2 The observed incidence
f AIN secondary to metamizole is 10.48 cases per 10,000
atient/year.1 Although previously described,3 it is not com-
on  to ﬁnd a Fanconi-type proximal tubulopathy.
In this case, features of AIN were found (isothenuria, non-
ephrotic proteinuria, rapid deterioration of GFR) along with
atures typical of a proximal tubulopathy (metabolic acidosis,
ycosuria with normoglycaemia, hyperphosphaturia, hype-
ricosuria, and generalised hyperaminoaciduria). The main
echanism was direct immune-mediated tubular toxicity
lated to metamizole. The second mechanism was tubu-
r necrosis secondary to renal vasoconstriction caused by
e inhibition of prostaglandins by metamizole (inhibition
f the enzyme COX-3) and gemﬁbrozole (stimulation of the
T
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Fa the inhibition of angiotensin II by valsartan. As in other
udies,4 renal failure developed between 1 and 3 weeks after
king the drug, was nonoliguric, without eosinophilia, skin
anges, or fever, and with characteristic abdominal pain and
roteinuria of around 1 g/day. The absence of deposits on DIF
d the fact that the patient developed symptoms on the sec-
nd exposure to the drug led us to think of an IgE-mediated
pe I hypersensitivity mechanism.
Notably, there was an increased anion gap (AG), which
as unexpected for a proximal renal tubular acidosis. We
led out consumption of salicylates, ethanol, propylene gly-
l and ethylene glycol, methanol, toluene, and other causes
at would explain l- and d-lactic acidosis. There was no
idence of rhabdomyolysis, and no measurable changes in
lasma calcium, magnesium, or albumin levels. We did not
nd any evidence in the medical literature that metamizole,
lsartan, or gemﬁbrozole increased AG by producing inter-
ediate metabolites. It is possible that the consumption of
aracetamol, by producing the metabolite 5-oxoproline, would
plain the ﬁnding.8,9 In fact, the patients had consumed it
rior admission, during his hospital admission and after dis-
arge. The acquired accumulation of 5-oxyproline is found in
ng-term paracetamol users, and occurs with normal blood
aracetamol levels. Predisposing circumstances are female
x, malnutrition, pregnancy, vegetarian diet, sepsis, chronic
nal failure, liver disease (mainly alcoholic), and the use of
rtain antibiotics and anticonvulsants.
The combined action of drugs that synergistically affect
e distal tubule (valsartan) and proximal tubule (metamizole
d genﬁbrozil3,7) could increase the chances of renal damage.his should be taken into account at the time of prescribing
em concurrently. It is worth considering the possibility that
e ﬁbrate might have played a role in the development of
nconi syndrome, given its action on the proximal tubule,
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although the timing of the clinical presentation makes this
less likely.
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Case  reports  and  misdiagnosis  of  renal  tubular  acidosis
Informe  de  casos  de  acidosis  tubular  renal  y  errores  de  diagnóstico
Dear Editor,
Renal tubular acidosis (RTA) is a pathophysiological alteration
of acid–base metabolism, characterised by the presence of
hyperchloraemic metabolic acidosis, which is caused by renal
loss of bicarbonate or a reduction in hydrogen ion excre-
tion by the renal tubules.1 A suspicion of RTA is based on
the clinical presentation of various signs and symptoms such
as anorexia, vomiting, polyuria, polydipsia, delayed growth,
muscle weakness, rickets, nephrocalcinosis and sensorineu-
ral deafness.2 The diagnosis is validated with laboratory
examinations that should include the demonstration of hyper-
chloraemic metabolic acidosis, with a normal blood anion gap
and a blood pH lower than 7.35, in patients with decompen-
sated metabolic acidosis. In the case of secondary RTA, it is
important to diagnose the systemic disease that is causing
it.1 It should be noted that intestinal losses of bicarbon-
ate, whether they are due to diarrhoea or a ﬁstula, are a
common cause of the same acid–base alterations, and so
they should not be present when a diagnosis of RTA i
made.
RTA has been reported to be overdiagnosed in Mexico,3,
and it has been associated with allergy.4–6 For this reason, we
conducted a study with the aim of documenting the diagnosi
of RTA in children from different hospitals. A total of 170 chil
dren with a prior diagnosis of RTA were enrolled; the majority
were receiving alkaline treatment. Treatment was suspended
5 to 7 days prior to the initial assessment, which consisted
of a medical history, laboratory examinations and an assess
ment by the allergy department. A diagnosis of RTA was only
conﬁrmed in 3 patients (1.8%), one with distal RTA and 2 with
RTA secondary to cystinosis, which were accompanied by Fan
coni syndrome. None of them had an allergy. The rest of the
patients’ prior diagnosis of RTA was erroneous; failure to thrive
was caused by other conditions such as nutritional deﬁciency
Turner syndrome, giardiasis, coeliac disease, familial shor
stature, hypophosphataemic rickets, coenzyme Q10 deﬁciency
or cardiomyopathy. The cases with RTA are described below. Please cite this article as: Medeiros M, Enciso S, Hernández AM, He
acidosis tubular renal y errores de diagnóstico. Nefrología. 2016;36:32rnández HRG, Toussaint G, Pinto C, et al. Informe de casos de
3–325.
